• In early June 2026, Synchrony Financial completed a US$500,000,000 fixed‑income offering of non‑convertible perpetual depositary shares and announced a variable‑rate fixed‑to‑floating version, while LiveLoveSpa.com disclosed a new partnership integrating CareCredit into its eCommerce checkout for beauty and wellness purchases.
• This combination of fresh funding and broader CareCredit access in online beauty retail highlights Synchrony’s push to deepen its presence in health and wellness financing across digital channels.
• We’ll now examine how integrating CareCredit into LiveLoveSpa.com’s online checkout experience may influence Synchrony’s existing investment narrative.

Rare earth metals are the new gold rush. Find out which 27 stocks are leading the charge.

Synchrony Financial Investment Narrative Recap

To own Synchrony Financial, you have to believe its partnerships and digital financing platforms can keep loan receivables and fees growing even as consumer behavior and credit costs shift. The LiveLoveSpa.com CareCredit integration fits the health and wellness expansion story, but by itself it does not materially change the near term tension between growth (loan volumes, purchase activity) and key risks like partner concentration and potential regulatory pressure on consumer fees.

Among recent developments, the US$500,000,000 perpetual preferred depositary share offering stands out here. It reinforces Synchrony’s already strong capital position at the same time the company is running a large buyback program and increasing common dividends, which matters if higher technology and compliance spending, or softer purchase volumes, start to weigh on profitability and investors focus more closely on balance sheet flexibility.

Yet beneath this positive capital story, there is still the underappreciated risk that softer purchase volumes and tighter credit actions could pressure future earnings that investors should be aware of...

Synchrony Financial's narrative projects $16.6 billion revenue and $3.0 billion earnings by 2029. This requires 18.9% yearly revenue growth and a $0.5 billion earnings decrease from $3.5 billion today.

Uncover how Synchrony Financial's forecasts yield a $89.22 fair value, a 26% upside to its current price.

Exploring Other Perspectives

The most pessimistic analysts were already assuming revenue of about US$16.7 billion and earnings near US$2.7 billion by 2029, so if you think credit tightening and weaker purchase volumes could bite harder than consensus expects, this new CareCredit and funding news might or might not shift that view, which is why it helps to compare several different forecasts before deciding how you feel about Synchrony’s risk and reward trade off.

Explore 7 other fair value estimates on Synchrony Financial - why the stock might be worth just $77.00!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Synchrony Financial research is our analysis highlighting 5 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Synchrony Financial research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Synchrony Financial's overall financial health at a glance.

Want Some Alternatives?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Uncover the next big thing with 24 elite penny stocks that balance risk and reward.
• Outshine the giants: these 13 early-stage AI stocks could fund your retirement.
• Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.